Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Chetan S Karyekar"'
Autor:
Kaiyin Fei, Peter C Taylor, Tom WJ Huizinga, Georg Schett, Matthew J Loza, Chetan S Karyekar, Bei Zhou, Jocelyn H Leu, Qingmin Wang, Keying Ma, Fowzia Ibrahim, Yuan Xiong, Sheng Gao, Sophia G Liva, Jafar Sadik B Shaik, Rohit A Panchakshari, Harman Dhatt, Ricardo Rojo Cella, Carolyn A Cuff
Publikováno v:
RMD Open, Vol 10, Iss 2 (2024)
Objectives To investigate the efficacy, safety, pharmacokinetics and pharmacodynamics of nipocalimab in participants with moderate to severe active rheumatoid arthritis (RA) and inadequate response or intolerance to ≥1 antitumour necrosis factor ag
Externí odkaz:
https://doaj.org/article/e8783e06cebd4815857f9ccfd2c182ba
Autor:
Chetan S Karyekar, Federico Zazzetti, Teresa A Simon, Urbano Sbarigia, Frédéric Lavie, Enkeleida Nikaï, Martine Lewi, Michel van Speybroeck, Reyhan Sonmez, Chureen Carter
Publikováno v:
Lupus Science and Medicine, Vol 11, Iss Suppl 2 (2024)
Externí odkaz:
https://doaj.org/article/ae96a746fa774b329e56615d066d25b0
Publikováno v:
Lupus Science and Medicine, Vol 9, Iss 1 (2022)
Objective To determine if achieving lupus low disease activity state (LLDAS) or remission prevents damage accrual in a primarily Mestizo population.Methods Patients with SLE from a single-centre cohort with at least two visits occurring every 6 month
Externí odkaz:
https://doaj.org/article/94db6d85153d4c2a88e8c1b5988eb780
Autor:
Atul Deodhar, Shihong Sheng, Philip S Helliwell, Soumya D Chakravarty, Elizabeth C Hsia, Enrique R Soriano, Chetan S Karyekar, Wolf-Henning Boehncke, Prasheen Agarwal, Christopher T Ritchlin, Alexa P Kollmeier, Federico Zazzetti, Ramanand A Subramanian, Xie L Xu, Qing C Zuraw, Yusang Jiang, Bei Zhou, Yanli Zhuang, May Shawi
Publikováno v:
RMD Open, Vol 7, Iss 1 (2021)
Objective Evaluation of the efficacy and safety of guselkumab, a human monoclonal antibody targeting the interleukin-23p19 subunit, in patients with psoriatic arthritis (PsA) through 1 year.Methods Adults who met ClASsification criteria for Psoriatic
Externí odkaz:
https://doaj.org/article/ae559d22818b49b5b84a51d05b30ba53
Autor:
Peter Nash, Atul Deodhar, Philip J Mease, Dafna D Gladman, Philip S Helliwell, Dennis G McGonagle, Alice Gottlieb, Elizabeth C Hsia, Chetan S Karyekar, Wolf-Henning Boehncke, Xie L Xu, Stephen Xu
Publikováno v:
RMD Open, Vol 6, Iss 2 (2020)
Objective To evaluate the effect of guselkumab on enthesitis and dactylitis in a phase II trial of patients with active psoriatic arthritis (PsA).Methods This was a phase II, randomised, placebo-controlled, double-blind trial of adults with active Ps
Externí odkaz:
https://doaj.org/article/508d7521b8de4678b046fdcdbb2ca02d
Autor:
Arthur Kavanaugh, Lianne S Gensler, Philip S Helliwell, Kristen Sweet, Yin You, Soumya D Chakravarty, Shelly Kafka, Chetan S Karyekar, Kim Campbell
Publikováno v:
RMD Open, Vol 6, Iss 1 (2020)
Background The interleukin-12/23p40-subunit-inhibitor ustekinumab significantly improved spondylitis-related symptoms through Week 24 in psoriatic arthritis (PsA) patients with peripheral arthritis and physician-reported spondylitis (PA-PRS) in PSUMM
Externí odkaz:
https://doaj.org/article/3be774b727244c9f891bb653b2fa9ad5
Autor:
Fruzsina Kósa, Péter Kunovszki, Judit Gimesi-Országh, Melinda Kedves, Melinda Szabó, Chetan S. Karyekar, György Nagy
Publikováno v:
Arthritis Research & Therapy, Vol 24, Iss 1, Pp 1-9 (2022)
Abstract Objectives The aim of this national population-based, retrospective database study is to compare the comorbidity profiles of systemic lupus erythematosus (SLE) patients and general population controls matched for age, gender, and region and
Externí odkaz:
https://doaj.org/article/c96b007612c4410287cb96ae1934b7ee
Publikováno v:
BMC Rheumatology, Vol 3, Iss 1, Pp 1-10 (2019)
Abstract Background The prevalence of mood disturbances such as anxiety and depression is greater in rheumatoid arthritis (RA) patients than in the general population. Given this association, the primary aim of this study was to assess the incrementa
Externí odkaz:
https://doaj.org/article/57b2177aa6404f9fa3303a2e2e40bafa
Autor:
Rangi Kandane-Rathnayake, Vera Golder, Worawit Louthrenoo, Yi-Hsing Chen, Jiacai Cho, Aisha Lateef, Laniyati Hamijoyo, Shue-Fen Luo, Yeong-Jian J Wu, Sandra V Navarra, Leonid Zamora, Zhanguo Li, Sargunan Sockalingam, Yasuhiro Katsumata, Masayoshi Harigai, Yanjie Hao, Zhuoli Zhang, B M D B Basnayake, Madelynn Chan, Jun Kikuchi, Tsutomu Takeuchi, Sang-Cheol Bae, Shereen Oon, Sean O'Neill, Fiona Goldblatt, Kristine Pek Ling Ng, Annie Law, Nicola Tugnet, Sunil Kumar, Cherica Tee, Michael Tee, Naoaki Ohkubo, Yoshiya Tanaka, DaeYoung Yu, Chetan S Karyekar, Chak Sing Lau, Julie A Monk, Mandana Nikpour, Alberta Hoi, Eric F Morand
Publikováno v:
The Lancet Rheumatology. 4:e822-e830
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e6fa0c432dba1357abd7048673959f4f
https://doi.org/10.1016/s2665-9913(22)00304-6
https://doi.org/10.1016/s2665-9913(22)00304-6
Autor:
Sean O'Neill, Madelynn Chan, Fiona Goldblatt, Zhanguo Li, Aisha Lateef, Laniyati Hamijoyo, C. S. Lau, Masayoshi Harigai, Ricardo Azêdo Montes, Yasuhiro Katsumata, Leonid Zamora, Eric F Morand, Rangi Kandane-Rathnayake, Yeong-Jian J Wu, Sargunan Sockalingam, Sang Cheol Bae, Shue-Fen Luo, Jiacai Cho, Yuan An, Worawit Louthrenoo, Yanjie Hao, Tsutomu Takeuchi, Zhuoli Zhang, Jun Kikuchi, Sandra V. Navarra, Alberta Hoi, Yi-Hsing Chen, Chetan S Karyekar, Vera Golder, Mandana Nikpour, Shereen Oon
Publikováno v:
Arthritis Care & Research. 74:2033-2041
Evidence for the utility of medications in settings lacking randomized trial data can come from studies of treatment persistence. The present study was undertaken to examine patterns of medication use in systemic lupus erythematosus (SLE) using data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81fe19d7ddc230ba344e25b6b8d3efbf
https://doi.org/10.1002/acr.24740
https://doi.org/10.1002/acr.24740